NCT04150653

Brief Summary

Abdominal aortic aneurysm (AAA) is an abnormal dilatation of the aorta in the abdomen due to a wall weakening caused by atherosclerosis. While indications for a rupture intervention are based on AAA maximal diameter (MaxD) (5 cm), 23% of ruptured AAAs are less than 5 cm and in large AAAs, rupture rate could be lower than expected. We propose to expand and validate our vascular ultrasound elastography software to 3D. Strain maps generated from radiofrequency (RF) data acquired from 30 AAA patients with a matrix-array 3D probe will be registered to conventional CT (phase 1) and validated to a biomechanical for characterization of AAA wall, assessing vulnerability and influence of surrounding tissues (phase 2). At the end of the project, we will have analyzed 3D strain maps to improve patient selection before surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 1, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 5, 2019

Completed
10 months until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 10, 2023

Status Verified

March 1, 2023

Enrollment Period

3.3 years

First QC Date

November 1, 2019

Last Update Submit

March 9, 2023

Conditions

Keywords

Abdominal aortic aneurysm rupture preventionNon-invasive vascular elastography by ultrasound3D mapping of AAA strainVascular vulnerability assessment

Outcome Measures

Primary Outcomes (1)

  • AAA strain measurement

    Measure of AAA strain values using imaging exams

    Within less than one month of their surgery

Secondary Outcomes (2)

  • AAA strain measurement determined by NIVE

    Within less than one month of their surgery

  • AAA strain measurement determined by multiphase CT

    Within less than one month of their surgery

Study Arms (1)

AAA patients

All patients enrolled in phase 1 will undergo: * Multiphase scan CT * Non-invasive vascular ultrasound elastography by ultrasound (NIVE)

Device: Multiphase scan CT, non-invasive vascular ultrasound elastography by ultrasound (NIVE)

Interventions

Multiphase scan CT, non-invasive vascular ultrasound elastography by ultrasound (NIVE)

Also known as: Multiphase scan CT, Non-invasive vascular ultrasound elastography by ultrasound (NIVE)
AAA patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The target population is adults with AAA scheduled for elective repair. For the purpose of this study, we will recruit AAA patients seen at the CHUM and Glen campus McGill University.

You may qualify if:

  • Patient with a documented AAA (CT-scan or ultrasound less than 6 months before enrollment) with a maximum diameter (max D) between 4.5 cm and 7 cm.

You may not qualify if:

  • Ruptured, symptomatic or not atheromatous aneurysm;
  • Renal failure (renal serum clearance \<50 mL/min);
  • Previous intervention on AAA (general or endovascular surgery);
  • BMI \>35;
  • Atrial fibrillation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier de l'Université de Montréal

Montreal, Quebec, H2X 0C1, Canada

RECRUITING

Study Officials

  • Samuel Kadoury, PhD

    Centre de recherche du centre hospitalier de l'Université de Montréal (CRCHUM) and Polytechnique Montréal

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 1, 2019

First Posted

November 5, 2019

Study Start

September 1, 2020

Primary Completion

December 31, 2023

Study Completion

December 31, 2024

Last Updated

March 10, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations